These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
691 related articles for article (PubMed ID: 27443278)
1. Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US. Jones E; Pike J; Marshall T; Ye X BMC Health Serv Res; 2016 Jul; 16():294. PubMed ID: 27443278 [TBL] [Abstract][Full Text] [Related]
2. Costs and quality of life of multiple sclerosis in Austria. Kobelt G; Berg J; Lindgren P; Plesnilla C; Baumhackl U; Berger T; Kolleger H; Vass K Eur J Health Econ; 2006 Sep; 7 Suppl 2():S14-23. PubMed ID: 17310339 [TBL] [Abstract][Full Text] [Related]
3. Costs and quality of life of multiple sclerosis in Switzerland. Kobelt G; Berg J; Lindgren P; Gerfin A; Lutz J Eur J Health Econ; 2006 Sep; 7 Suppl 2():S86-95. PubMed ID: 17310338 [TBL] [Abstract][Full Text] [Related]
4. Burden of a multiple sclerosis relapse: the patient's perspective. Oleen-Burkey M; Castelli-Haley J; Lage MJ; Johnson KP Patient; 2012; 5(1):57-69. PubMed ID: 22217263 [TBL] [Abstract][Full Text] [Related]
5. Costs and quality of life of multiple sclerosis in Italy. Kobelt G; Berg J; Lindgren P; Battaglia M; Lucioni C; Uccelli A Eur J Health Econ; 2006 Sep; 7 Suppl 2():S45-54. PubMed ID: 17310336 [TBL] [Abstract][Full Text] [Related]
6. Costs and quality of life of multiple sclerosis in the United Kingdom. Kobelt G; Berg J; Lindgren P; Kerrigan J; Russell N; Nixon R Eur J Health Econ; 2006 Sep; 7 Suppl 2():S96-104. PubMed ID: 17310341 [TBL] [Abstract][Full Text] [Related]
7. Costs and quality of life in multiple sclerosis in The Netherlands. Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343 [TBL] [Abstract][Full Text] [Related]
8. Costs and quality of life of multiple sclerosis in Spain. Kobelt G; Berg J; Lindgren P; Izquierdo G; Sánchez-Soliño O; Pérez-Miranda J; Casado MA; Eur J Health Econ; 2006 Sep; 7 Suppl 2():S65-74. PubMed ID: 17310340 [TBL] [Abstract][Full Text] [Related]
9. Costs and quality of life of multiple sclerosis in Germany. Kobelt G; Berg J; Lindgren P; Elias WG; Flachenecker P; Freidel M; König N; Limmroth V; Straube E Eur J Health Econ; 2006 Sep; 7 Suppl 2():S34-44. PubMed ID: 17310337 [TBL] [Abstract][Full Text] [Related]
10. Costs and quality of life for patients with multiple sclerosis in Belgium. Kobelt G Eur J Health Econ; 2006 Sep; 7 Suppl 2():S24-33. PubMed ID: 17318662 [TBL] [Abstract][Full Text] [Related]
11. Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis. Ruutiainen J; Viita AM; Hahl J; Sundell J; Nissinen H J Med Econ; 2016; 19(1):21-33. PubMed ID: 26360615 [TBL] [Abstract][Full Text] [Related]
12. Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability. Casado V; Martínez-Yélamos S; Martínez-Yélamos A; Carmona O; Alonso L; Romero L; Moral E; Gubieras L; Arbizu T BMC Health Serv Res; 2006 Nov; 6():143. PubMed ID: 17078879 [TBL] [Abstract][Full Text] [Related]
13. The burden of multiple sclerosis in Japan. Nohara C; Hase M; Liebert R; Wu N J Med Econ; 2017 Dec; 20(12):1290-1298. PubMed ID: 28849983 [TBL] [Abstract][Full Text] [Related]
14. Treatment experience, burden, and unmet needs (TRIBUNE) in multiple sclerosis: the costs and utilities of MS patients in Canada. Karampampa K; Gustavsson A; Miltenburger C; Kindundu CM; Selchen DH J Popul Ther Clin Pharmacol; 2012; 19(1):e11-25. PubMed ID: 22247419 [TBL] [Abstract][Full Text] [Related]
15. Costs and quality of life of multiple sclerosis in Sweden. Berg J; Lindgren P; Fredrikson S; Kobelt G Eur J Health Econ; 2006 Sep; 7 Suppl 2():S75-85. PubMed ID: 17310342 [TBL] [Abstract][Full Text] [Related]
16. Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study. da Silva NL; Takemoto MLS; Damasceno A; Fragoso YD; Finkelsztejn A; Becker J; Gonçalves MVM; Tilbery C; de Oliveira EML; Callegaro D; Boulos FC BMC Health Serv Res; 2016 Mar; 16():102. PubMed ID: 27009599 [TBL] [Abstract][Full Text] [Related]
17. Impact on healthcare resource utilization of multiple sclerosis in Spain. Sicras-Mainar A; Ruíz-Beato E; Navarro-Artieda R; Maurino J BMC Health Serv Res; 2017 Dec; 17(1):854. PubMed ID: 29284493 [TBL] [Abstract][Full Text] [Related]
18. New insights into the burden and costs of multiple sclerosis in Europe: Results for Poland. Selmaj K; Kobelt G; Berg J; Orlewska E; Capsa D; Dalén J; Mult Scler; 2017 Aug; 23(2_suppl):130-142. PubMed ID: 28643586 [TBL] [Abstract][Full Text] [Related]
19. Importance of an individual's evaluation of functional status for health-related quality of life in patients with multiple sclerosis. Gavelova M; Nagyova I; Rosenberger J; Krokavcova M; Gdovinova Z; Groothoff JW; van Dijk JP Disabil Health J; 2015 Jul; 8(3):372-9. PubMed ID: 25981341 [TBL] [Abstract][Full Text] [Related]
20. New insights into the burden and costs of multiple sclerosis in Europe: Results for Hungary. Péntek M; Kobelt G; Berg J; Capsa D; Dalén J; Bíró Z; Mátyás K; Komoly S; Mult Scler; 2017 Aug; 23(2_suppl):91-103. PubMed ID: 28643591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]